Skip Navigation Skip to content

Research & Development Centre, Bangalore

Shilpa Medicare is coming up with state of Art Centralized Research and Development Centre at Dobaspet near Bangalore for Formulation Development. The Research and Development Centre is involved in development Oncology and Non – Oncology Injectable, Oncology and Non – Oncology ODF, Transdermal or topical applications, Ophthalmic and Orally Disintegrating Films formulation.

The Research & Development activities at Shilpa Medicare are designed to be carried out in full compliance to sound Intellectual Property principles in vogue. The product pipeline and patent portfolio management is efficiently harmonized and overseen by the Intellectual Property Management & Legal Affairs Cell

Driving innovation and maximizing value through its Research and Development operations – the Centre is well equipped for development of Generics, Complex Generics and new dosage forms involving Nano and micro technologies like liposomes, Nano particles and speciality products.

On Analytical front, the Research and Development Centre is equipped with state of the art instruments to evaluate the all kinds of dosage forms. We have also established facility for evaluate the in-house extractable & leachable for all our products and have capabilities of characterization of API, impurities, excipients and packing components.

The new Research and Development Centre is one point stop to customers for Product development, can cater the product development along with analytical method development for finished product, analytical method validation, stability studies, characterization of impurities, evaluating extractable & leachable for packing components. Process Development Lab is meeting the cGMP requirement for manufacture scale – up batches to optimize the process variables and to manufacture of clinical batches.

The Research and Development Centre can be catering, for CRO for Non – Oncology products along with analytical support and as CRAMS for Oncology portfolio of customers.

hit counter